HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of intestinal ischemia-reperfusion injury in humanized mice.

AbstractBACKGROUND:
Ischemia-reperfusion injury (I/R) is an inflammatory response to hypoxia that is dependent on antibodies. We have previously shown that the N2 peptide blocks binding of autoreactive antibody to ischemic tissue and reduces I/R injury in rodents. Whether these same antibodies exist and target the same antigen in humans is unknown. In this study, we create a novel "humanized" mice model of intestinal I/R and test the efficacy of N2.
METHODS:
Humanized mice were generated by transplanting human lymphocytes into immunodeficient mice. Human T- and B-cell engraftment in the spleen and peritoneum was confirmed using flow cytometry, and circulating human antibody in mouse serum was measured with ELISA. Injury in the small intestine and lung after intestinal I/R was measured in the presence or absence of N2. Immunohistochemistry was used to assess for human antibody deposition in the small intestine.
RESULTS:
Humanized mice engrafted with functional CD20+ B cells generated high circulating serum levels of human antibody. N2 treatment significantly reduced intestinal injury severity scores after I/R (control: 28 ± 1.5, N2: 9.1 ± 3.4; P < .05). N2 also attenuated remote lung inflammation after I/R (control: 28 ± 4, N2: 5.4 ± 1.3; P < .05). Protection from I/R injury correlated with blockade of human antibody deposition on small intestine.
CONCLUSION:
N2 is an effective therapy for I/R injury in the presence of human immunity, supporting a conserved target of inflammatory attack in human reperfusion injury.
AuthorsEric G Sheu, Kohei Wakatsuki, Sean Oakes, Michael C Carroll, Francis D Moore Jr
JournalSurgery (Surgery) Vol. 160 Issue 2 Pg. 436-42 (08 2016) ISSN: 1532-7361 [Electronic] United States
PMID27086922 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2016 Elsevier Inc. All rights reserved.
Chemical References
  • Immunoglobulin Isotypes
  • Nonmuscle Myosin Type IIA
Topics
  • Animals
  • Disease Models, Animal
  • Immunoglobulin Isotypes (metabolism)
  • Intestine, Small (immunology, metabolism, pathology)
  • Lymphocytes (physiology)
  • Male
  • Mice
  • Mice, Inbred NOD
  • Nonmuscle Myosin Type IIA (immunology)
  • Reperfusion Injury (etiology, metabolism, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: